An Open-Label Pilot Study to Compare the Efficacy of Escalating Doses of IncobotulinumtoxinA (Xeomin) in the Treatment of Glabellar Rhytids.
Phase of Trial: Phase IV
Latest Information Update: 12 Dec 2017
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- 17 Apr 2015 New trial record